Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Astrazeneca plc crawled time : 15:30 save search
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman
Published: 2024-02-27 (Crawled : 15:30) - biospace.com/
AZNCF | $140.15 560
|
Health Technology
|
| O: -1.72%
H: 2.54%
C: 2.54%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: 0.01%
H: 0.79%
C: 0.6%
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | $140.15 560
|
Health Technology
|
| O: -0.57%
H: 0.04%
C: -1.74%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -1.46%
H: 1.04%
C: 0.97%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: -0.48%
BMY | $48.145 0.64% 2.5M
|
Health Technology
|
| O: 0.02%
H: 0.46%
C: -0.14%
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: -0.83%
H: 0.7%
C: -0.27%
ABT | News | $105.52 -0.36% 1.6M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: -1.77%
H: 0.46%
C: 0.41%
AMGN | $265.48 0.53% 360K
|
Health Technology
|
| O: -0.4%
H: 1.6%
C: 1.54%
report health treatment care global market
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | $140.15 560
|
Health Technology
|
| O: -3.0%
H: 2.15%
C: 2.15%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -0.44%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -1.31%
H: 0.56%
C: -0.17%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: -2.23%
H: 0.28%
C: -0.11%
reach research market
AstraZeneca to Acquire Icosavax, Including Potential First-in-class RSV and hMPV Combination Vaccine With Positive Phase II Data
Published: 2023-12-12 (Crawled : 15:30) - biospace.com/
AZNCF | $140.15 560
|
Health Technology
|
| O: 5.03%
H: 0.0%
C: -3.82%
ICVX | $15.31 -0.65% 9.3M
|
|
| O: 53.48%
H: 1.02%
C: 0.26%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: 1.54%
H: 0.06%
C: -0.78%
vaccine astrazeneca positive acquire rsv potential
Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: -0.23%
H: 1.45%
C: 0.97%
civo partnership pharma drug technology
AstraZeneca advances scientific leadership in hematology at ASH 2023
Published: 2023-11-29 (Crawled : 15:30) - biospace.com/
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: 1.33%
H: 0.3%
C: -0.03%
astrazeneca
Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | $140.15 560
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -0.63%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 0.52%
H: 0.57%
C: -0.56%
GSK | $39.44 -0.4% 560K
|
Health Technology
|
| O: -0.5%
H: 0.26%
C: -0.69%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
BMY | $48.145 0.64% 2.5M
|
Health Technology
|
| O: -0.37%
H: 1.54%
C: 0.89%
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: -0.04%
H: 0.76%
C: -0.16%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: 0.19%
H: 0.03%
C: -1.57%
AMGN | $265.48 0.53% 360K
|
Health Technology
|
| O: 0.22%
H: 0.15%
C: -0.98%
disease tumor market
Global Intranasal Drug Delivery Market to Reach $71.3 Billion by 2026
Published: 2022-03-03 (Crawled : 15:30) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 2.8%
H: 0.0%
C: -8.16%
AZNCF | $140.15 560
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: -0.06%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.27%
H: 0.0%
C: 0.0%
GSK | $39.44 -0.4% 560K
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
ATR | $139.13 0.53% 57K
|
Process Industries
|
| O: -0.26%
H: 0.73%
C: 0.38%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: -2.63%
H: 0.9%
C: -0.3%
drug liver drug delivery
China Oncology Drugs Market to Cross $35.2 Billion by 2027 - Insights Into the Leading Therapies, Indications, Drugs, and Companies
Published: 2022-02-18 (Crawled : 15:30) - prnewswire.com
AZNCF | $140.15 560
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: -2.99%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: -0.73%
H: 0.23%
C: -0.98%
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: -0.19%
H: 0.72%
C: -0.46%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: -1.02%
H: 0.43%
C: -0.84%
drug china therapy
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
SMSI 4 | $2.53 29.74% 510K
|
Technology Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.